Mild Primary or Breakthrough SARS-CoV-2 Infection Promotes Autoantibody Production in Individuals with and without Neuro-PASC
Lavanya Visvabharathy(Northwestern University), Igor J. Koralnik(Northwestern University), Patrick H. Lim(Royal Prince Alfred Hospital), Millenia Jimenez(Northwestern University), Neda Dalil Roofchayee(Northwestern University), Chengsong Zhu(The University of Texas Southwestern Medical Center), Zachary S. Orban(Northwestern University), Lucia Leonor(Northwestern University), Pablo Penaloza‐MacMaster(Northwestern University)
Cited by 7
Related Papers
Fulminant Myocarditis with Combination Immune Checkpoint Blockade
|New England Journal of Medicine|2016|2.3k
Persistent neurologic symptoms and cognitive dysfunction in non‐hospitalized Covid‐19 “long haulers”
|Annals of Clinical and Translational Neurology|2021|715
Evolution of neurologic symptoms in non‐hospitalized <scp>COVID</scp>‐19 “long haulers”
|Annals of Clinical and Translational Neurology|2022|71
Plasma Biomarkers of Neuropathogenesis in Hospitalized Patients With COVID-19 and Those With Postacute Sequelae of SARS-CoV-2 Infection
|Neurology Neuroimmunology & Neuroinflammation|2022|64
Neurologic Manifestations of Long <scp>COVID</scp> Differ Based on Acute <scp>COVID</scp>‐19 Severity
|Annals of Neurology|2023|52